These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33211210)
1. Microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (MOG) antibody-associated optic neuritis. Jang YJ; Kim SM; Kim SJ; Jung JH Neurol Sci; 2021 May; 42(5):2129-2131. PubMed ID: 33211210 [No Abstract] [Full Text] [Related]
2. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165 [TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study. Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Kezuka T; Ishikawa H Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571 [TBL] [Abstract][Full Text] [Related]
8. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis. Liu H; Zhou H; Wang J; Sun M; Teng D; Song H; Xu Q; Wei S J Neurol Sci; 2019 Jan; 396():225-231. PubMed ID: 30522039 [TBL] [Abstract][Full Text] [Related]
14. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199 [TBL] [Abstract][Full Text] [Related]
15. Differential patterns of interhemispheric functional connectivity between AQP4-optic neuritis and MOG-optic neuritis: a resting-state functional MRI study. Sun M; Zhou H; Xu Q; Yang M; Xu X; Zhou M; Wei S Acta Radiol; 2021 Jun; 62(6):776-783. PubMed ID: 32660318 [TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis. Tajfirouz DA; Bhatti MT; Chen JJ Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369 [TBL] [Abstract][Full Text] [Related]
17. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis]. Wei SH; Zhao Y Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. Martinez-Hernandez E; Sepulveda M; Rostásy K; Höftberger R; Graus F; Harvey RJ; Saiz A; Dalmau J JAMA Neurol; 2015 Feb; 72(2):187-93. PubMed ID: 25506781 [TBL] [Abstract][Full Text] [Related]
19. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein. Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy. Liu H; Zhou H; Wang J; Xu Q; Wei S Br J Ophthalmol; 2019 Oct; 103(10):1423-1428. PubMed ID: 30514710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]